首页 > 市场调查报告书 > 医疗设备

体外诊断

免疫诊断市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1899730

免疫诊断市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测

Immunodiagnostics Market Size, Share, and Growth Analysis, By Product (Instruments, Reagents & Consumables), By Application (Infectious Diseases, Oncology & Endocrinology), By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，免疫诊断试剂市场规模将达到 251.9 亿美元，到 2025 年将达到 262.5 亿美元，到 2033 年将达到 364.8 亿美元，预测期（2026-2033 年）的复合年增长率为 4.2%。

全球慢性病、感染疾病和自体免疫疾病的增加，推动了对免疫诊断的需求，因为医疗机构更加重视提升诊断能力和早期检测。这种日益增长的关注度有望为免疫诊断公司创造巨大的机会。诊断技术的创新和个人化医疗的转变预计将进一步推动需求。此外，居家医疗和远端医疗的日益普及预计将推动家庭免疫诊断市场的扩张。加上医疗保健成本不断上涨和人口老化，这些因素为市场相关人员带来了良好的前景。然而，法规结构不一致、报销障碍、训练有素的专业人员短缺、操作流程复杂以及假阳性风险等挑战可能会阻碍市场的整体扩张。

推动免疫诊断市场发展的因素

全球免疫诊断市场的主要驱动因素是慢性病和感染疾病的日益流行，这推动了对精准高效诊断工具的需求。随着医疗保健系统向预防性和个人化医疗转型，对可靠诊断方法的需求激增，这些方法能够识别和监测癌症、自体免疫疾病和感染疾病等疾病。免疫诊断检测技术的进步，以及人们对这些检测的认知度和可近性的提高，进一步促进了市场成长。这些因素共同作用，提高了早期诊断和治疗的能力，从而改善了患者的预后，并推动了市场扩张。

限制免疫诊断市场发展的因素

全球免疫诊断市场的主要限制因素之一是先进诊断设备和试剂的高成本。安装和维护先进免疫诊断系统的相关成本可能构成障碍，尤其对于发展中地区的中小型医疗机构和实验室而言更是如此。这种经济障碍会限制创新诊断技术的普及，阻碍其广泛应用。此外，严格的产品核可监管要求也减缓了新型免疫诊断解决方案的推出，这给那些希望在不断变化的竞争格局和医疗需求中拓展市场份额的製造商带来了更多挑战。

免疫诊断市场趋势

免疫诊断市场正经历重大变革，即开发能够同时检测多种生物标记的多重检测技术，从而提高临床诊断的效率和资源管理水平。这一趋势的驱动力在于市场对能够实现快速、准确筛检的综合诊断解决方案的需求日益增长。随着医疗机构寻求透过简化检测流程来改善患者预后，在单次检测中获取多种健康资讯的能力变得至关重要。专注于这项创新的公司有望凭藉其在不断发展的免疫诊断解决方案领域的领先地位，获得竞争优势。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Abbott（US）
Roche Diagnostics（Switzerland）
DiaSorin（Italy）
Danaher Corporation（US）
QIAGEN（Netherlands）
bioMerieux（France）
Thermo Fisher Scientific（US）
Quest Diagnostics（US）
Siemens Healthineers AG（Germany）
Bio-Rad Laboratories, Inc.（US）
Sysmex Corporation（Japan）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Mindray Medical International Limited（China）
Grifols, SA（Spain）
Becton, Dickinson and Company（BD）（US）
Abcam plc（UK）
Merck KGaA（Germany）
Enzo Biochem, Inc.（US）
Bio-Techne Corporation（US）
Meso Scale Diagnostics, LLC.（US）
GenScript Biotech Corporation（China）
Myriad Genetics, Inc.（US）

简介目录

Product Code: SQMIG35A2401

Immunodiagnostics Market size was valued at USD 25.19 Billion in 2024 and is poised to grow from USD 26.25 Billion in 2025 to USD 36.48 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global rise in chronic, infectious, and autoimmune diseases is driving an increased need for immunodiagnostics, as healthcare providers prioritize enhanced diagnostic capabilities and early detection. This growing focus is likely to create significant opportunities for immunodiagnostics companies. Innovations in diagnostic technology and a shift towards personalized medicine are set to further increase demand. Additionally, the increasing trend of home and remote healthcare practices is expected to boost the market for home-based immunodiagnostics. Coupled with heightened healthcare expenditures and a growing elderly population, these factors present promising prospects for market players. However, challenges such as inconsistent regulatory frameworks, reimbursement hurdles, a shortage of trained professionals, complex procedures, and the risk of false positives could hinder overall market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunodiagnostics Market Segments Analysis

Global Immunodiagnostics Market is segmented by Product, Application, End user, and region. Based on Product, the market is segmented into Instruments, and Reagents & Consumables. Based on Application, the market is segmented intoOncology& Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, and Others. Based on End user, the market is segmented into Clinical Laboratories, Hospitals, Physician's Offices, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Immunodiagnostics Market

A key market driver for the global immunodiagnostics market is the increasing prevalence of chronic and infectious diseases, which amplifies the demand for accurate and efficient diagnostic tools. As healthcare systems increasingly shift towards preventive care and personalized medicine, the need for reliable diagnostic methods to identify and monitor conditions such as cancer, autoimmune disorders, and infectious diseases has surged. Technological advancements in immunodiagnostic assays, along with the rising awareness and accessibility of these tests, further contribute to market growth. These factors collectively enhance the capacity for early diagnosis and treatment, thereby improving patient outcomes and driving market expansion.

Restraints in the Immunodiagnostics Market

One key market restraint for the global immunodiagnostics market is the high cost of advanced diagnostic equipment and reagents. The expenses associated with acquiring and maintaining sophisticated immunodiagnostic systems can be prohibitive, particularly for small and medium-sized healthcare facilities and laboratories in developing regions. This financial barrier may limit access to innovative diagnostic technologies, hindering widespread adoption and utilization. Furthermore, stringent regulatory requirements for product approval can slow down the introduction of new immunodiagnostic solutions, creating additional challenges for manufacturers aiming to increase market presence amidst rising competition and evolving healthcare needs.

Market Trends of the Immunodiagnostics Market

The immunodiagnostics market is witnessing a significant shift towards the development of multiplex tests, designed to simultaneously detect multiple biomarkers, thereby enhancing efficiency and resource management in clinical diagnostics. This trend is driven by an increasing demand for comprehensive diagnostic solutions that facilitate rapid and accurate screening. As healthcare providers seek to improve patient outcomes through streamlined testing processes, the ability to capture diverse health information in a single assay is becoming paramount. Companies focusing on this innovation are likely to gain competitive advantages, positioning themselves at the forefront of the evolving landscape of immunodiagnostics solutions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Immunodiagnostics Market by Product

Market Overview
Instruments
Reagents & Consumables

Immunodiagnostics Market by Application

Market Overview
Oncology & Endocrinology
Hepatitis & Retrovirus
Cardiac Markers
Infectious Diseases
Others

Immunodiagnostics Market by End user

Market Overview
Clinical Laboratories
Hospitals
Physician's Offices
Online Pharmacies

Immunodiagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meso Scale Diagnostics, LLC. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments